WHO ICTRP trial
Testing for genetic changes in breast cancer
CTRI/2024/10/075022 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/10/075022 |
|---|---|
| Public title | Testing for genetic changes in breast cancer |
| Scientific title | Genetic Screening of Epigenetic Modifiers in Newly Diagnosed Breast Cancer Patients. - NIL |
| Primary sponsor | Intramural Fund, MAHE, Manipal |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: C501- Malignant neoplasm of central portion of breast Health Condition 2: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 3: C505- Malignant neoplasm of lower-outerquadrant of breast Health… |
| Interventions | Intervention1: NIL: NIL Control Intervention1: NIL: NIL |
| Registration date | Sep 10, 2024 |
| Target size | 20 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: